Blinatumomab (AMG-10,MT-103) is a CD19/CD3 bispecific B-cell and T-cell binding antibody that directs T-cells to attack cancer cells by binding to both CD3 on T-cells and CD19 on cancer cells, and is used in acute lymphoblastic leukemia and non-Hodgkins lymphoma.
Purity:
>90%
CAS Number:
[853426-35-4]
Target:
Immunology/Inflammation related|||Integrin
* VAT and and shipping costs not included. Errors and price changes excepted